Journal: eLife
Article Title: Sigh generation in preBötzinger complex
doi: 10.7554/eLife.100192
Figure Lengend Snippet: ( a–d ) Optogenetic activation of SST neurons generates sighs after blockade of NMBRs and GRPRs. ( a ) Top: Schematic of the genetic strategy to target preBötC SST neurons. Bottom: Schematic depicting bilateral placement of optical cannula targeting preBötC. ( b ) Ectopic sigh (red arrowhead) elicited by bilateral SPP (gray box) of preBötC SST neurons. ( c ) V T (t 4 =0.176, p=0.863), T I (t 4 =1.355, p=0.200), T E (t 4 =0.734, p=0.477) of ectopic sighs before blockade or V T (t 4 =0.856, p=0.409), T I (t 4 =0.894, p=0.389) of ectopic sighs after blockade of NMBR and GRPR were no different from endogenous sighs (n=5 mice). T E of ectopic sighs elicited after blockade was longer than that of endogenous sighs (t 4 =4.960, p=3 × 10 –4 ). V T , T I , and T E of ectopic sighs before (V T : t 4 =7.925, p=4 × 10 –6 ; T I : t 4 =11.194, p=10 –7 ; T E : t 4 =5.405, p=10 –4 ) or after (V T : t 4 =7.245, p=10 –5 ; T I : t 4 =13.442, p=10 –8 ; T E : t 4 =9.631, p=5 × 10 –7 ) blockade were increased compared with eupneic breaths (n=5 mice), indicative of augmented breaths with postsigh apneas. Statistical significance was determined with a One-Way RM ANOVA followed by All Pairwise Multiple Comparison Procedures (Holm-Sidak method), V T : F 3,16 = 30.357, p<0.001; T I : F 3,16 = 78.526, p<0.001; T E : F 3,16 = 31.134, p<0.001. ( d ) SPP elicits sighs in the presence of GRPR antagonist RC3095 and NMBR antagonist BIM23042. ( e, f ) Chemogenetic activation of SST neurons generated sighs after blockade of NMBRs and GRPRs. ( e ) Top: schematic diagram of genetic strategy to selectively express DREADD receptor hM3Dq on preBötC SST neurons. Bottom: representative trace of airflow and V T during baseline, after application of clozapine-n-oxide (CNO), and after microinjection of RC3095 and BIM23042. ( f ) Top: Activation of hM3Dq receptors expressed on preBötC SST + neurons significantly decreased breathing f , increased V T , and elevated sigh frequency; subsequent BIM23042 and RC3095 (B+R) microinjection into preBötC did not significantly affect breathing f , V T , nor sigh rate induced by CNO application (repeated measures ANOVA, n=3 mice; f : F 2,4 = 28.3, p=0.004; V T : F 2,4 = 25.7, p=0.005; sigh rate: F 2,4 = 26.1, p=0.005). Bottom: representative trace depicting sighs during baseline, after application of CNO, and after microinjection of NMBR and GRPR antagonists RC3095 and BIM23042. ( g ) Top: schematic diagram of genetic strategy to selectively express ultrapotent inhibitory DREADD receptor PSAM4-GlyR on preBötC SST + neurons. Bottom: representative trace of airflow and V T during baseline, after preBötC microinjection of peptides NMB and GRP (250 µM each, 50 nl/side), and application of uPSEM817 (10 mM, 30 µl applied to brainstem surface). ( h ) Top: Microinjection of peptides NMB and GRP into preBötC significantly decreased breathing f, increased V T , and elevated sigh frequency; subsequent inhibition of SST + preBötC neurons selectively eliminated any sighs, but preserves decreased f and V T (repeated measures ANOVA, n=3 mice; f: F 2,4 = 55.8, p=0.001; V T : F 2,4 = 19.0, p=0.009; sigh rate: F 2,4 = 83.8, p<0.001). Bottom: representative trace depicting sighs during baseline, after bilateral preBötC microinjection of NMB and GRP, and after application of PSAM4-GlyR ligand uPSEM817 to the brainstem surface. Data are shown as mean ± SE. Asterisks indicate post-hoc multiple comparison test or paired t-test results: *, significance with p<0.05; **, significance with p<0.01.
Article Snippet: To express ChR2 selectively in preBötC neurons, AAV injections were performed on adult Sst Cre mice (Jackson Labs Strain #013044) or Grpr flp mice.
Techniques: Activation Assay, Comparison, Generated, Microinjection, Inhibition